Hylinate Lotion

Manufacturer
Artesa Labs, LLC
Effective date
2020-01-13
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 23:46:25

Label at a glance#

ProductHylinate
Active ingredientHYALURONATE SODIUM
Label structure11 sections

Dosage and administration

Apply to the affected area(s) and rub in thoroughly. Use a liberal amount two to three times daily or as directed by a physician.

Storage and handling

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized. NOTICE: Protect from freezing and excessive heat. Keep container tightly closed.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

DESCRIPTION

DESCRIPTION SECTION

Each mL contains 1 mg of sodium hyaluronate, carbomer 980, imidazolidinyl urea, methylparaben, propylparaben, purified water, and triethanolamine.

INDICATIONS

INDICATIONS & USAGE SECTION

This product is indicated in the treatment of symptoms associated with xerosis (dry, scaly skin).

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

WARNINGS

WARNINGS SECTION

KEEP OUT OF REACH OF CHILDREN.

PRECAUTIONS

PRECAUTIONS SECTION

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

General: This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.

Information for Patients: Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or elsewhere. Avoid contact with eyes, lips and mucous membranes.

Carcinogenesis, Mutagenesis and Impairment of Fertility: Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.

Pregnancy: Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.

Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

If any adverse reaction occurs, discontinue use and seek the attention of a physician.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Apply to the affected area(s) and rub in thoroughly. Use a liberal amount two to three times daily or as directed by a physician.

STORAGE

STORAGE AND HANDLING SECTION

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

NOTICE: Protect from freezing and excessive heat. Keep container tightly closed.

HOW SUPPLIED

HOW SUPPLIED SECTION

This product is supplied in the following size(s):
12 fl. oz. (340 mL) bottles, NDC 57893-314-12

To report a serious adverse event or obtain product information, call 1-855-899-4237.

Manufactured for:
Artesa Labs, LLC
13785 Research Blvd.
Suite 125
Austin, TX 78750

1900293 [00] Rev. 01/2020

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label.jpglabel.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
57893-31457893-314-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
HYALURONATE SODIUMYSE9PPT4THACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a2157f27-e59d-400b-e053-2995a90a83e59c0af50f-0f2f-cc8c-e053-2995a90ab2f62020-03-30Warnings, Adverse reactionsExact identifier
spl set id: 9c0af50f-0f2f-cc8c-e053-2995a90ab2f6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.